Bull
$36.73
Scenario price
$28.000
-0.148 (-0.53%)At close
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
Celsius Holdings Inc is currently priced at $28.47, which is significantly lower than the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E ratio of 16.86, suggesting it may be overvalued given its recent performance. The company reported a substantial revenue increase of 85.5% year-over-year, reaching nearly $2.5 billion, but its net income of $108 million indicates ongoing expansion costs. The main risk is its heavy reliance on Pepsi, which accounted for 43.2% of its revenue, exposing it to potential distribution issues.
Morgan Stanley
$42
2026-09-17
Morgan Stanley
2026-09-17
Price Target
$42
Deutsche Bank
$35
2026-08-27
Deutsche Bank
2026-08-27
Price Target
$35
Goldman Sachs
$45
2026-08-10
Goldman Sachs
2026-08-10
Price Target
$45
Stephens
$50
2026-08-10
Stephens
2026-08-10
Price Target
$50
Morgan Stanley
$42
2026-08-07
Morgan Stanley
2026-08-07
Price Target
$42
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Celsius Faces Competition from Monster in Market Analysis

Celsius Holdings Class Action Reminder
Investment Analysis: Celsius vs. Colgate-Palmolive

Celsius Holdings Class Action Notice Issued

Comparing Growth Potential of CAVA and Celsius
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).
Celsius Holdings Inc is currently priced at $28.47, which is significantly lower than the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E ratio of 16.86, suggesting it may be overvalued given its recent performance. The company reported a substantial revenue increase of 85.5% year-over-year, reaching nearly $2.5 billion, but its net income of $108 million indicates ongoing expansion costs. The main risk is its heavy reliance on Pepsi, which accounted for 43.2% of its revenue, exposing it to potential distribution issues.
1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.

$CELH looks like it's finally starting to curl off long-term support here. There's a lot of room to drift up from here within this triangle ⤴️ The 50 WMA is $36.73.
Show more
$CELH could realistically consolidate until June 2027. It has about 8 months of room left before it reaches the apex of this massive symmetrical triangle, before it could break out and start the next bull run or leg up. Not financial advice, just food for thought. Shares are probably the best way to go to avoid theta decay.
Show more
$CELH below $30 isn't an attractive short. It's a $100 stock with a good COO.
Show more
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.